FNY Investment Advisers »

Taysha Gene Therapies shares owned by FNY Investment Advisers

Quarter-by-quarter ownership of Taysha Gene Therapies (TSHA) shares owned by FNY Investment Advisers from 13F filings

Historical chart of FNY Investment Advisers investment in Taysha Gene Therapies

Tip: Access up to 7 years of quarterly data

All positions including Taysha Gene Therapies held by FNY Investment Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Taysha Gene Therapies by FNY Investment Advisers

Quarter filed Position value Share count Share price at filing
2025-09-30 $14k 4.3k 3.26

More positions owned by FNY Investment Advisers

Verona Pharma Plc ads (VRNA)
NVIDIA Corporation (NVDA)
UnitedHealth (UNH)
Sibanye Stillwater Adr Rep 4 Ord Sponsored Adr (SBSW)
Copper Property Control Pass-T (CPPTL)
Codere Online Luxembourg Ord (CDRO)
iShares Barclays 20+ Yr Treas.Bond (TLT)
Microsoft Corporation (MSFT)
Fnma 0.000 preferred (FNMFN)
Churchill Cap Corp X
Seagate Technology Com Stk
Futurecrest Acquisition Corp
Sigma Lithium Corporation (SGML)
Taiwan Semiconductor Mnftg Adr 5 Ord Sponsored Adr (TSM)
Boeing Company (BA)

View all positions for FNY Investment Advisers

Top funds holding Taysha Gene Therapies

Rtw Investments
RA Capital Management
venBio Select Advisor
BlackRock
FMR
Goldman Sachs Group
Vanguard Group
Siren
Octagon Capital Advisors
Point72 Asset Management
State Street Corporation
Vestal Point Capital
Deerfield Management Company
Polar Capital Holdings
Geode Capital Management

View all funds holding Taysha Gene Therapies